SCHEMBL29482201

SCHEMBL29482201

CN(C)C(=O)c1cccc(F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.61
CES1 P23141 2/20 0.61
PARP1 P09874 1/20 0.57
OPRM1 P35372 1/20 0.54
OPRL1 P41146 1/20 0.54
HDAC1 Q13547 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
TSHR P16473 1/20 0.53
ERN1 O75460 2/20 0.50
GRM1 Q13255 1/20 0.48
POLB P06746 1/20 0.47
PLA2G7 Q13093 1/20 0.47
CDK4 P11802 1/20 0.47
CCND1 P24385 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
FYN P06241 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL255000 1.00 CES2 (0.61) CES2CES1PARP1OPRM1OPRL1
SCHEMBL12469445 0.89 ERN1 (0.59) CES2CES1PARP1OPRM1OPRL1
SCHEMBL7406706 0.85 MEN1 (0.55) ERN1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL30424341 0.85 PARP1 (0.58) CES2CES1PARP1OPRM1OPRL1
Hydrochloric Acid SCHEMBL25222262 0.83 PARP1 (0.56) CES2CES1PARP1OPRM1OPRL1
SCHEMBL13412201 0.82 CES2 (0.53) CES2CES1PARP1OPRM1OPRL1
SCHEMBL305837 0.82 CES2 (0.53) CES2CES1PARP1OPRM1OPRL1
SCHEMBL29729945 0.82 CES2 (0.53) CES2CES1PARP1OPRM1OPRL1
SCHEMBL7223254 0.82 GRM5 (0.53) CES2CES1PARP1OPRM1OPRL1
SCHEMBL12706704 0.80 TSHR (0.54) CES2CES1PARP1OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705292-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF Arcus Biosciences, Inc. (US) 2026-03-11 EP disclosed
WO-2024233360-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2024-11-14 WO disclosed